<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Akkus, Funda</dc:creator>
  <dc:creator>Treyer, Valerie</dc:creator>
  <dc:creator>Johayem, Anass</dc:creator>
  <dc:creator>Ametamey, Simon M.</dc:creator>
  <dc:creator>Gomez Mancilla, Baltazar</dc:creator>
  <dc:creator>Sovago, Judit</dc:creator>
  <dc:creator>Buck, Alfred</dc:creator>
  <dc:creator>Hasler, Gregor</dc:creator>
  <dc:date>2016</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">Background: Nicotine addiction is a major public health problem and is associated with primary glutamatergic dysfunction. We recently showed marked global reductions in metabotropic glutamate receptor type 5 (mGluR5) binding in smokers and recent ex-smokers (average abstinence duration of 25 weeks). The goal of this study was to examine the role of mGluR5 downregulation in nicotine addiction by investigating a group of long-term ex-smokers (abstinence &gt;1.5 years), and to explore associations between mGluR5 binding and relapse in recent ex-smokers.&#13;
&#13;
Methods: Images of mGluR5 receptor binding were acquired in 14 long-term ex-smokers, using positron emission tomography with radiolabeled [11C]ABP688, which binds to an allosteric site with high specificity.&#13;
&#13;
Results: Long-term ex-smokers and individuals who had never smoked showed no differences in mGluR5 binding in any of the brain regions examined. Long-term ex-smokers showed significantly higher mGluR5 binding than recent ex-smokers, most prominently in the frontal cortex (42%) and thalamus (57%).&#13;
&#13;
Conclusions: Our findings suggest that downregulation of mGluR5 is a pathogenetic mechanism underlying nicotine dependence and the high relapse rate in individuals previously exposed to nicotine. Therefore, mGluR5 receptor binding appears to be an effective biomarker in smoking and a promising target for the discovery of novel medication for nicotine dependence and other substance-related disorders.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/327577</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/327577/files/akkusetal.2016.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1016/j.biopsych.2015.02.027</dc:relation>
  <dc:relation>info:eu-repo/semantics/altIdentifier/issn/0006-3223</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>Rights reserved</dc:rights>
  <dc:source>Biological Psychiatry. - Amsterdam : Elsevier BV. - 2016, vol. 79, no. 6, p. 474-480</dc:source>
  <dc:subject xmlns:ns1="xml" ns1:lang="en">Abstinence</dc:subject>
  <dc:subject xmlns:ns2="xml" ns2:lang="en">Addiction</dc:subject>
  <dc:subject xmlns:ns3="xml" ns3:lang="en">Glutamate</dc:subject>
  <dc:subject xmlns:ns4="xml" ns4:lang="en">Nicotine</dc:subject>
  <dc:subject xmlns:ns5="xml" ns5:lang="en">Relapse</dc:subject>
  <dc:subject xmlns:ns6="xml" ns6:lang="en">mGluR5</dc:subject>
  <dc:subject>info:eu-repo/classification/udc/616</dc:subject>
  <dc:title xmlns:ns7="xml" ns7:lang="en">Association of Long-Term Nicotine Abstinence With Normal Metabotropic Glutamate Receptor-5 Binding</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
